Skip to content

Compare pain efficacy with and without iliopsoas plane block in patients undergoing total hip arthroplasty

Analgesic Efficacy of Iliopsoas Plane Block in Total Hip Arthroplasty : A Randomised Controlled Trial - nil

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/069175
Enrollment
56
Registered
2024-06-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M169- Osteoarthritis of hip, unspecified Health Condition 2: M169- Osteoarthritis of hip, unspecified Health Condition 3: M161- Unilateral primary osteoarthritisof hip

Interventions

Intervention1: Iliopsoas Plane Block: Single dose of 10ml 0.5% ropivacaine is given in iliopsoas plane after induction of general anaesthesia Control Intervention1: General anaesthesia given without a

Sponsors

All India Institute of Medical Sciences, Patna
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients planned for total hip arthroplasty ASA I, II, III patients Age group 20- 70 years

Exclusion criteria

Exclusion criteria: Patient refusal ASA IV High risk patients who may require post operative ICU care Infection over target site Bleeding diathesis Allergic to local anaesthetic

Design outcomes

Primary

MeasureTime frame
To compare the postoperative opioid consupmtion with and without iliopsoas plane 24hr post operativelyTimepoint: At 1hr, 6hr, 12hr, 24hr postoperatively

Secondary

MeasureTime frame
Muscle power at 1hr 6hr 12hr 24hr postoperativelyTimepoint: At 1hr, 6hr, 12hr,24 hr postoperatively;NRS score at 1hr 6hr 12hr 24hr postoperativelyTimepoint: At 1hr, 6hr, 12hr, 24hr postoperatively;Patient satisfactionTimepoint: 24 hr postoperatively;Post operative time to 1st rescue analgesiaTimepoint: from the time of administration of block to the first need of resue analgesic administration;Postoperative nausea and vomitingTimepoint: 24 hr postoperatively

Countries

India

Contacts

Public ContactDr Ajeet Kumar

AIIMS PATNA

ajeetanaes@gmail.com9312501413

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026